FDA Guidance Provides Relief for MDR Reporting During a Pandemic
Exeed Regulatory Compliance
MARCH 22, 2020
Timely MDR reporting is a challenging regulatory requirement for the industry. A new FDA guidance provides much-needed relief during a pandemic. Adverse event reporting requirements are very stringent, and late reporting of such events is a routine focus of FDA inspections and subsequent warning letters.
52 
Let's personalize your content